The board should be able to follow the obligation

An insurer accepts obligations before every cost and payment date is known. I think its governance should make that continuing uncertainty examinable without pretending that the board can remove it by requesting a more confident forecast. At Yorihama Assurance, I prepare the financial account as CFO and participate in the board as an executive director. My preparation duties remain management duties. My board responsibility asks me to consider the institution beyond the convenience of the finance function's own presentation.

The first distinction I preserve is between specialist judgement and its financial explanation. Actuarial colleagues assess claims estimates through their professional work. Claims leadership owns the handling of individual files, while underwriting leadership decides within its authority which commitments the insurer accepts. Finance connects these contributions to the accounts, cash plan and resource decisions. I ask difficult questions of the evidence, but I do not use my title to substitute an earnings preference for an actuarial conclusion or a coverage decision.

When an older liability cohort required a JPY2.4 billion increase in its gross claims estimate, the board needed to see that movement separately from stronger recent underwriting. In the case presented, no reinsurance recovery offset the increase. We therefore explained the full pre-tax earnings consequence and the separate timing of payments. The fact that the result was unwelcome did not reduce the need for an accessible account of the assumptions. The history of that cohort remained relevant after the reporting decision, and I asked for later development to be compared with the dated earlier view.

Reinsurance raises a related question about the stage a financial asset has reached. A receivable may be recognised while collection still depends on documents, interpretation or an agreed settlement process. I keep the material delays and expected next events available to the cash discussion. Our collection programme followed a fixed opening cohort and left its JPY1.3 billion remainder visible. The board could then assess progress, continuing work and resource requirements without mistaking a balance-sheet total for cash already available to meet policyholder obligations.

I apply the same patience to portfolio decisions. Stopping renewals from a JPY6.2 billion-premium book changed future activity but left a service tail. An eighteen-person team and JPY240 million first-year budget remained necessary. I asked the board to approve the strategic withdrawal with those consequences attached. Subsequent reviews consider the nature and value of the remaining work, rather than treating a falling file count as automatic permission to remove an equivalent share of capability. Claim assessment standards remain separate from a desire to make the exit look faster.

Investment oversight requires a different form of patience. A proposed system can deserve exploration before it deserves its entire funding envelope. We released JPY380 million for an initial phase within a JPY1.1 billion proposal, including the cost of testing migration and running parallel processes. The later decision depended on evidence rather than the mere passage of time. I want directors to understand what a stage could change, what it costs to preserve that choice and who will explain an unfavourable result if the test does not support the original plan.

Committee papers should allow the responsible specialists to be heard, including when their assessments do not produce a simple consensus. I favour a clear recommendation accompanied by the material disagreements and the conditions for returning to the decision. The board should know which matter requires its approval and which belongs within management's delegated work. That helps avoid both extremes: a board receiving only polished conclusions and a board becoming a second operating committee that takes over the preparation it is meant to challenge.

For an external appointment, I would bring these questions without assuming that an insurer's arrangements fit another enterprise. I would learn its commitments, owners and operating responsibilities first. I would also disclose relevant insurer and commercial relationships, preserve confidential material and test my available time against the actual calendar. The useful contribution is a disciplined curiosity about obligations that outlast the initial transaction. It should strengthen the board's ability to examine management's account while leaving competent management room to carry out the work for which it remains accountable.